Cargando…

MPC-7 Clinical features of Diffuse hemispheric glioma, H3 G34-mutant in children and young adults

INTRODUCTION: H3F3A G34R/V mutated gliomas are seen predominantly in children and young adults, and have been proposed as “Diffuse hemispheric glioma, H3 G34-mutant” in cIMPACT-NOW Update 6. However, the clinical features of the tumor have not been fully elucidated. METHODS: We retrospectively revie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeshima, Yuki, Kuroda, Jyun-Ichiro, Kawano, Tatsuya, Matsuura, Jin, Matsuzaki, Hiroaki, Itoyama, Takashi, Kai, Keitarou, Takezaki, Tatsuya, Shinojima, Naoki, Mukasa, Akitake
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648200/ http://dx.doi.org/10.1093/noajnl/vdab159.062

Ejemplares similares

ML-17 Clinical usefulness of Tirabrutinib in recurrent PCNSL: single institute experience
por: Matsuura, Jin, et al.
Publicado: (2021)

MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT
por: Takezaki, Tatsuya, et al.
Publicado: (2019)

ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma
por: Takezaki, Tatsuya, et al.
Publicado: (2020)

ML-15 The future direction of treatment development for primary central nervous system lymphoma (PCNSL)
por: Shinojima, Naoki, et al.
Publicado: (2020)

COT-18 Trends in Primary Brain Tumors in Kumamoto Prefecture with Declining Birthrate and Aging Population - Kumamoto Prefecture Brain Tumor Epidemiological Survey
por: Shinojima, Naoki, et al.
Publicado: (2021)

IM-8 Significance of IL-1 pathways in Glioblastoma
por: Kai, Keitaro, et al.
Publicado: (2021)

MPC-5 Characteristics of H3 G34-mutant gliomas
por: Kibe, Yuji, et al.
Publicado: (2021)

GCT-36. TREATMENT RESULTS AND RADIATION-INDUCED TUMORS IN CASES OF CENTRAL NERVOUS SYSTEM GERM CELL TUMOR: A LONG-TERM FOLLOW-UP STUDY IN KUMAMOTO PREFECTURE
por: Yamamoto, Takahiro, et al.
Publicado: (2020)

MLTI-15. A CASE SERIES OF PRE-OPERATIVE GAMMA-KNIFE RADIOSURGERY FOR RESECTABLE BRAIN METASTASES
por: Takezaki, Tatsuya, et al.
Publicado: (2019)

BOT-02 2-METHYLTHIO MODIFICATION OF N6-ISOPENTENYLADENOSINE IN MITOCHONDRIAL TRNAS BY CDK5RAP1 PROMOTES THE MAINTENANCE OF GLIOMA-INITIATING CELLS
por: Yamamoto, Takahiro, et al.
Publicado: (2019)

MPC-11 Comprehensive gene expression analysis of IDH-mutated astrocytomas with 19q-loss
por: Otani, Ryohei, et al.
Publicado: (2020)

CS-03 LARGE CYSTIC INTRADURAL SCHWANNOMA IN CERVICAL REGION: A CASE REPORT
por: Takeshima, Yuki, et al.
Publicado: (2019)

CS-07 A CYSTIC LONG-SEGMENT CERVICAL SCHWANNOMA: A CASE REPORT
por: Takeshima, Yuki, et al.
Publicado: (2019)

Gliosarcoma with Systemic Metastasis Showing Favorable Response to Ifosfamide, Carboplatin, and Etoposide Chemotherapy: An Autopsy Case Report
por: NAKAGAKI, Yuki, et al.
Publicado: (2022)

MPC-2 Clinical course and prognosis of lower-grade glioma, IDH wildtype and pTERT mutant
por: Takahashi, Yoshinobu, et al.
Publicado: (2021)

Atypical pituitary abscess lacking rim enhancement and diffusion restriction with an unusual organism, Moraxella catarrhalis: A case report and review of the literature
por: Kawano, Tatsuya, et al.
Publicado: (2021)

A Consideration of Optimal Head Position in Transsylvian Selective Amygdalohippocampectomy
por: HAMASAKI, Tadashi, et al.
Publicado: (2023)

CS-6 A case of poorly differentiated chordoma with systemic metastasis
por: Shinojima, Naoki, et al.
Publicado: (2021)

ML-03 RECONSIDERATION OF TREATMENT FOR ELDERLY PATIENTS WITH PRIMARY CENTRAL NERVE SYSTEM LYMPHOMAS
por: Shinojima, Naoki, et al.
Publicado: (2019)

CBMS-09 Intercellular communication at glioblastoma stem cell niches
por: Hide, Takuichiro, et al.
Publicado: (2020)

EPID-01. TRENDS OF INCIDENCE IN PEDIATRIC BRAIN TUMORS IN KUMAMOTO PREFECTURE, JAPAN
por: Itoyama, Takashi, et al.
Publicado: (2020)

MPC-10 Prognostic analysis in IDH mutant astrocytoma patient with CDKN2A/B homozygous deletion
por: Yanagisawa, Shunsuke, et al.
Publicado: (2021)

MPC-04 Utility of comprehensive cancer genome analysis for brain tumors
por: Miwa, Kazuhiro, et al.
Publicado: (2020)

Importance of Age and Noncontrast-Enhancing Tumor as Biomarkers for Isocitrate Dehydrogenase–Mutant Glioblastoma: A Multicenter Study
por: Uetani, Hiroyuki, et al.
Publicado: (2023)

EPEN-02. EVALUATION OF TREATMENT OUTCOMES AND EXPRESSION OF EMT-RELATED TRANSCRIPTION FACTORS AS NOVEL THERAPEUTIC TARGETS IN PEDIATRIC EPENDYMOMA
por: Makino, Keishi, et al.
Publicado: (2020)

2-Methylthio Conversion of N6-Isopentenyladenosine in Mitochondrial tRNAs by CDK5RAP1 Promotes the Maintenance of Glioma-Initiating Cells
por: Yamamoto, Takahiro, et al.
Publicado: (2019)

MPC-4 Malignant transformation of diffuse low-grade gliomas: systematic review and meta-analysis
por: Nakasu, Satoshi, et al.
Publicado: (2021)

MPC-1 DNA methylome analysis suggested the presence of “true” IDH-wildtype lower-grade gliomas
por: Satomi, Kaishi, et al.
Publicado: (2021)

MPC-13 The evaluation of the shift of trend in lower grade glioma diagnoses based on each era`s criteria
por: Pareira, Eriel Sandika, et al.
Publicado: (2021)

MPC-06 Cutting-edge of Cancer Genomic Medicine for brain tumors
por: Mizoguchi, Masahiro, et al.
Publicado: (2020)

MPC-17 2021 WHO Classification of Tumors of the CNS, 5th ed
por: Komori, Takashi
Publicado: (2021)

Antitumor effect of fibrin glue containing temozolomide against malignant glioma
por: Anai, Shigeo, et al.
Publicado: (2014)

MPC-02 Prognostic effects of molecular factors in elderly patients with IDH-wildtype Glioblastomas
por: Fukai, Junya, et al.
Publicado: (2020)

Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
por: Picart, Thiébaud, et al.
Publicado: (2021)

MPC-8 Serum anti-zinc finger FYVE domain-containing protein 21 (ZFYVE21) autoantibody as a novel biomarker for oligodendroglioma IDH-mutant and 1p/19q co-deletion
por: Matsutani, Tomoo, et al.
Publicado: (2021)

MPC-6 Clinical significance of whole chromosomal aberration signatures in non-metastatic medulloblastomas treated with 18Gy of craniospinal irradiation
por: Fukuoka, Kohei, et al.
Publicado: (2021)

SDPS-08 OSSEOUS METASTASES IN H3G34-MUTANT DIFFUSE HEMISPHERIC GLIOMAS
por: Yu, Nina, et al.
Publicado: (2023)

MPC-08 Molecular risk stratification using genome-wide DNA methylation data of standard-risk medulloblastomas treated with 18-Gy craniospinal irradiation
por: Irikura, Tomoya, et al.
Publicado: (2020)

Characteristics of brain metastases from esophageal carcinoma
por: Yamamoto, Takahiro, et al.
Publicado: (2014)

New Treatment Strategies to Eradicate Cancer Stem Cells and Niches in Glioblastoma
por: Hide, Takuichiro, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jd4afp4nguda6euljvuhrv8atg